All relevant data are within the paper and supporting information files.

Introduction {#sec001}
============

Body dysmorphic disorder (BDD) is characterized by excessive concerns about perceived flaws in one's appearance (e.g. a crooked nose, skin blemishes, or not being sufficiently muscular in the case of the muscle dysmorphia \[MD\] subtype) and associated behavioral or mental rituals to hide, improve, or control these flaws \[[@pone.0233153.ref001]\]. Despite being a debilitating disorder \[[@pone.0233153.ref002], [@pone.0233153.ref003]\] with high rates of suicidality \[[@pone.0233153.ref004]\], research interest in this area has only begun to grow in the last few years. Recently, the diagnostic entity of BDD has been reassigned: While it was classified as a subtype of hypochondriasis in the Somatoform Disorders category in the fourth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), it now represents a stand-alone diagnosis within the Obsessive-Compulsive and Related Disorders (OCRD) category in the DSM-5 \[[@pone.0233153.ref005], [@pone.0233153.ref006]\]. It is also set to be replaced accordingly in the upcoming 11^th^ version of the International Classification of Diseases (ICD; see online release version; \[[@pone.0233153.ref007]\]). While there is a broad agreement on the similarities between BDD and obsessive-compulsive disorder (OCD) \[[@pone.0233153.ref008]--[@pone.0233153.ref013]\], the empirical fit of the BDD diagnosis within this category has not yet been tested. Such confirmation might have important implications for both research and practice, for instance with regard to comorbidity screenings, improved clinical decision making, and information for the (further) development both of interventions and of etiological models.

The previous classification of BDD as a disorder which was "hidden" behind hypochondriasis or illness anxiety disorder within the category of Somatoform Disorders \[[@pone.0233153.ref005], [@pone.0233153.ref006], [@pone.0233153.ref014]\] has long been criticized \[[@pone.0233153.ref015]\]. While BDD and somatoform disorders such as hypochondriasis or pain disorder indeed share some symptoms targeting the body in phenomenological terms \[[@pone.0233153.ref006]\], they differ regarding other demographic variables (e.g. age and marital status) and clinical variables such as the focus of concern (i.e. worrying about physical health vs. worrying about appearance) \[[@pone.0233153.ref016]\]. Moreover, several somatoform disorders and BDD \[[@pone.0233153.ref017], [@pone.0233153.ref018]\] amongst other disorders share a heightened likelihood for dissociation and thus might be linked via dissociation as a psychopathological organizer \[[@pone.0233153.ref019], [@pone.0233153.ref020]\]. Despite widespread discussion, no study to date has tested the empirical fit of BDD within a spectrum encompassing these disorders in a so-called somatoform model.

The new classification of BDD as a stand-alone diagnosis in the category of OCRD in the DSM-5 \[[@pone.0233153.ref006]\] is mainly a response to criticisms of the previous version \[[@pone.0233153.ref021]\], and is mirrored by the proposed ICD-11 criteria \[[@pone.0233153.ref007]\]. It meets the expectation that disorders which are grouped together should not only present comparably on a phenomenological level (for instance intrusive thoughts and compulsive behavior in both OCD and BDD \[[@pone.0233153.ref006]\]), but should also show similarities in various clinical aspects, e.g. comorbidity, heredity, effective treatments, and treatment outcomes (again supported for OCD and BDD) \[[@pone.0233153.ref008]--[@pone.0233153.ref013], [@pone.0233153.ref022]\]. The relationships of BDD with the other disorders in this new DSM-5 category, namely hoarding disorder, trichotillomania, and excoriation disorder, are less strong, and the combination of these disorders under the umbrella of OCRD has been criticized \[[@pone.0233153.ref023]\]. Thus, while this category might be more empirically derived than the previous one, as it takes into account more diverse disorder-related aspects (see above), no study has yet tested the new classification of BDD into an OCRD spectrum by testing a so-called OCRD model with regard to its fit to the data.

In addition to the limited empirical validation of the current category, several studies have provided evidence that in terms of the function of core symptoms, comorbidity, family history, and treatment response, BDD might be more strongly linked to disorders from the Anxiety Disorder category (e.g. social anxiety disorder \[SAD\] and panic disorder) than to the other disorders from the OC spectrum. In particular, several reviews highlighted the similarities between and relatedness of BDD and SAD \[[@pone.0233153.ref023]--[@pone.0233153.ref026]\]. There is also evidence of an association with depression across important domains including comorbidity, family history, course of the disorder, and cognitive biases \[[@pone.0233153.ref027], [@pone.0233153.ref028]\]. Thus, conceptualizing BDD as a disorder within a broader affective spectrum alongside anxieties, OCD, and depression might be another option (affective model).

Moreover, there is a fair amount of research hinting at a comparability of BDD and eating disorders. These disorders not only share the hallmark feature of a disturbed body image \[[@pone.0233153.ref029]\], but also show resemblances regarding onset and course as well as cognitive biases \[[@pone.0233153.ref030]--[@pone.0233153.ref032]\], with a particular similarity between anorexia nervosa and BDD \[[@pone.0233153.ref031]\]. Therefore, it has been proposed that BDD and the eating disorders might form a body image spectrum of disorders \[[@pone.0233153.ref033]\]. Such a categorization could also have the advantage of including muscle dysmorphia (MD), a subtype of BDD. The classification of MD has been a topic of discussion ever since it was coined as "reverse anorexia" by Pope et al. \[[@pone.0233153.ref034]\], given its large symptom overlap with the eating disorders \[[@pone.0233153.ref035]\]. Dos Santos Filho et al. \[[@pone.0233153.ref036]\] concluded from a systematic review that there is not sufficient scientific evidence to support the inclusion of MD in any existing category of psychological disorders. However, a conceptualization of BDD with MD as a subtype, in a body image disorders spectrum within a so-called body image model that also includes eating disorders, might pave the way for future discussions \[[@pone.0233153.ref037]\].

Finally, BDD still shows some unique features with respect to symptomatology, which actually complicates its identification and treatment \[[@pone.0233153.ref038]\]. This indicates that BDD might be seen as a unique factor which is separate from somatoform, affective, and eating disorders, as has already been suggested in an adolescent sample \[[@pone.0233153.ref039]\]. A major benefit of such a BDD model may lie in greater diagnostic accuracy and better treatment, by prompting health care workers to check for the unique characteristics of BDD \[[@pone.0233153.ref040]\].

Despite the aforementioned evidence to support the various classification suggestions, no investigation has been conducted using a bottom-up approach, with the exception of the aforementioned study in adolescents by Schneider and colleagues \[[@pone.0233153.ref039]\], which supported the BDD-only model. That is, no study has used real data across various symptoms and fitted these data to stipulated classification models. While Schneider et al. \[[@pone.0233153.ref039]\] provided valuable insights into the uniqueness of BDD symptoms in the classification in adolescents; their sample had a narrow age range (around the age of onset of BDD). Moreover, other relevant psychopathology (e.g. depressive symptoms, eating disorders; \[[@pone.0233153.ref041], [@pone.0233153.ref042]\]) has not yet been comprehensively examined. Furthermore, Schneider et al.'s study failed to include the BDD subtype MD, which may have influenced the proximity to eating disorders in terms of classification. As the study also excluded somatoform disorders, the authors were unable to provide information about the usefulness of the DSM-IV/ ICD-10 classification of BDD. Finally, the study did not include OC-related disorders other than OCD itself, such as skin picking and hair pulling, thus reducing the informative value of the OCRD model.

Therefore, the aim of the present study was to provide empirically derived recommendations for the classification of BDD and MD in adults. We thus analyzed the best classification of both BDD and MD symptoms based on shared phenomenological and comorbidity aspects, taking into account various different aspects of related psychopathology such as those of OC and related disorders (OCD, skin picking, and hair pulling), eating disorders, SAD and panic disorders, depression, illness anxiety disorder, and somatoform disorder. To assess these aspects of psychopathology, a large community and student sample completed an online survey. Based on the reviewed literature, mainly of transdiagnostic studies comparing BDD mostly with OCD, eating disorders, anxiety, and depression as well as the study by Schneider and colleagues \[[@pone.0233153.ref039]\] analyzing psychopathological data in adolescents, but also past and current classification of BDD, six potential classification models were specified. Models differed according to their classification of BDD symptoms within different categories and consisted of a general psychopathology (in which one factor loaded on all indicators), somatoform, an OCRD, an affective, a body image, and a BDD model. The best fitting model was also tested with respect to equivalence in male and female subsamples due to differences in prevalence rates of disorders included as well as gender-specific subtypes of specific disorders, in particular BDD with the subtype MD. Furthermore, the models were retested in a subgroup that indicated primary concerns other than weight and shape on the questionnaire assessing BDD symptoms. This should rule out an inadvertent overestimation of the association between eating disorder and BDD pathology due to high scores on the BDD measures originally stemming from high shape and weight concerns.

Materials and method {#sec002}
====================

Participants and recruitment {#sec003}
----------------------------

The ethics committee of Osnabrück University has approved the study (no approval number available). Written informed consent was obtained by the participants. Recruitment was conducted through university press releases at the institutions of most authors, advertisements on social media and flyers, with the aim to recruit a non-clinical community sample of participants aged 18 years and older. We chose a community-based rather than a clinical sample in order to ensure that the comorbidity structures were representative of the general population \[[@pone.0233153.ref043]\]. Of *N* = 1166 persons who began the survey, *n* = 743 completed it (i.e., filled out all questionnaires included in this main manuscript results of two further questionnaires will be reported elsewhere); three participants were excluded as they were below the age of 18 years and four participants were excluded because they did not clearly identify as male or female. Thus, 736 participants were included in the analyses. As reimbursement for study participation, all participants who completed the survey were given the opportunity to enter a raffle to win one of 20 online shopping vouchers worth 20 Euros each, or received student credit if they were students at one of the participating institutions.

Procedure {#sec004}
---------

The questionnaires (see description below) were programmed in the online survey software Unipark (QuestBack GmbH, Cologne Germany). The landing page of the survey informed potential participants about the study aim (assessment of various different symptoms in order to improve assessment and consequently treatment options) and duration (approximately 45 minutes) as well as privacy and confidentiality aspects of the study. After providing informed consent and completing completing the survey, participants who indicated their interest in taking part in the raffle or in receiving student credits were redirected to a separate page on which they provided their contact information.

Measures {#sec005}
--------

In the following, the employed measures are described in order of their appearance in the survey. If not otherwise indicated the total scores of the instruments were employed. Instruments were chosen based on their brevity, representativeness of symptomatology, and frequency of use. Internal consistencies of these scores are presented in [Table 1](#pone.0233153.t001){ref-type="table"} and are good to excellent.

10.1371/journal.pone.0233153.t001

###### Univariate statistics and reliability of symptom measures.

![](pone.0233153.t001){#pone.0233153.t001g}

  Symptoms          Measure     Mean   *SD*   Range   *k*   α
  ----------------- ----------- ------ ------ ------- ----- -----
  BDD               FKS         0.94   0.69   0..4    16    .92
  Eating disorder   EDE-Q       1.65   1.44   0..6    22    .96
  Depressive        PHQ-9       0.87   0.64   0..3    9     .89
  OCD               OCI-R       0.74   0.57   0..4    18    .88
  Health anxiety    mSHAI       2.13   0.92   1..5    14    .95
  Somatoform        HEALTH-49   0.98   0.71   0..4    7     .78
  SAD               LSAS        0.74   0.51   0..3    48    .96
  MD                MDDI        2.06   0.60   1..5    13    .78
  Skin picking      SPS-R       0.33   0.57   0..4    8     .93
  Hair pulling      MGHHPS      0.06   0.29   0..4    7     .93
  Panic             ACQ         1.45   0.45   1..5    14    .83

*N* = 736. Range = minimum and maximum value of response scale. *k* = number of items. α = Cronbach's alpha. BDD, body dysmorphic disorder; OCD, obsessive-compulsive disorder; SAD, social anxiety disorder; MD, muscle dysmorphia.

### Demographic questionnaire {#sec006}

Assessed demographic and clinical variables included gender, age, sexual orientation, educational attainment, psychotropic medication, and current or lifetime diagnosis of a mental disorder.

The German-language *Body Dysmorphic Symptoms Inventory* (Fragebogen Körperdysmorpher Symptome, FKS; \[[@pone.0233153.ref044]\]) consists of 18 items assessing body dysmorphic disorder symptoms. The items can be summed into two subscales: "Specific BDD Symptoms" (items 1, 4--15) and "Associated Features" (items 16--18). Items are scaled from 0 "not at all, never, do not think about it" to 4 "very strongly so, over 5-times a week, over 8 hours a day".

The *Muscle Dysmorphia Disorder Inventory* (MDDI; \[[@pone.0233153.ref045]\]; German version; \[[@pone.0233153.ref046]\]) is a 13-item measure assessing symptoms associated with MD on three subscales (Drive for Size, Appearance Intolerance, Functional Impairment). Each item is rated on a 5-point Likert scale ranging from 1 "never" to 5 "always".

The *Eating Disorder Examination-Questionnaire* (EDE-Q; German-language version; \[[@pone.0233153.ref047]\]) assesses eating disorder psychopathology referring to the past 28 days. It consists of 22 items which are allocated to four subscales (Dietary Restraint, Eating Concern, Weight Concern, and Shape Concern), and scaled on a seven-point Likert scale from 0 "no day, not at all" to 6 "each day, markedly". Six additional items assess the frequencies of eating disorder behaviors, but were not used in the present study.

The *Obsessive-Compulsive Inventory-Revised* (OCI-R; German-language version; \[[@pone.0233153.ref048]\]) is an 18-item questionnaire assessing OCD symptom severity within the last month. Each item is rated on a 5-point Likert scale ranging from 0 "not at all" to 4 "extremely". The OCI-R comprises six subscales (Washing, Obsessing, Hoarding, Ordering, Checking, and Neutralizing).

The *Liebowitz Social Anxiety Scale* (LSAS; German-language version; \[[@pone.0233153.ref049]\]) assesses avoidance and fear in 24 situations that are likely to elicit social anxiety. Thirteen of the 24 items refer to performance situations and the remaining eleven items assess social interaction situations. For each of the 24 situations, the clinician derives ratings of avoidance and fear experienced by the respondent in the past week on a 4-point Likert scale. The fear scale ratings range from 0 "no fear" to 3 "severe fear" while the avoidance ratings also range from 0 to 3 (based on the percentage of time spent avoiding the particular situation from 0 "never" to 3 "usually" \[67--100%\]").

The *Patient Health Questionnaire* depression module (PHQ-9; German-language version; \[[@pone.0233153.ref050]\]) is a nine-item measure of depression severity. The items are rated on a 4-point Likert scale ranging from 0 "not at all" to 3 "nearly every day".

The *Short Health Anxiety Inventory*, modified version (mSHAI; German-language version; \[[@pone.0233153.ref051]\]) comprises 14 items assessing the severity of health anxiety. Items are rated on a 5-point Likert scale ranging from 1 "strongly disagree" to 5 "strongly agree".

The *Massachusetts General Hospital Hairpulling Scale* (MGHHPS; \[[@pone.0233153.ref052]\] unpublished German translation) assesses the severity of repetitive hair pulling. It contains seven items, which are rated on a 5-point Likert scale from 0 "no urges, none, always in control" to 4 "near constant, extreme, never able to distract".

The *Skin Picking Scale-Revised* (SPS-R; German-language version; \[[@pone.0233153.ref053]\]) measures skin picking disorder severity and impairment using eight items rated on a 5-point Likert scale from 0 "none" to 4 "extreme".

From the *Hamburg Modules for the Assessment of Psychosocial Health*, short version (HEALTH-49 Kurzform; Hamburger Module zur Erfassung allgemeiner Aspekte psychosozialer Gesundheit für die therapeutische Praxis; \[[@pone.0233153.ref054]\]), we used the subscale Physical Complaints for the present study. This subscale contains seven items asking about physical pain or complaints in the last two weeks, rated on a 5-point Likert scale from 1 "not at all" to 5 "extremely".

The German-language *Questionnaire on Body-Related Fears*, *Cognitions and Avoidance* (AKV; Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung; \[[@pone.0233153.ref055]\]) measures the severity of panic disorder symptoms. It encompasses the German versions of three questionnaires: the Body Sensation Questionnaire (BSQ; \[[@pone.0233153.ref056]\]), the Agoraphobic Cognitions Questionnaire (ACQ; \[[@pone.0233153.ref056]\]) and the Mobility Inventory (MI; \[[@pone.0233153.ref057]\]). In the present study, only the ACQ was used. The ACQ assesses the frequency of frightening or maladaptive thoughts about the consequences of panic and anxiety. It contains 14 items rated on a 5-point Likert scale ranging from 1 "thought never occurs" to 5 "thought always occurs when I am nervous".

Data analysis {#sec007}
-------------

Structural equation modeling (SEM) analyses were conducted with R v3.5.0 using the package lavaan v0.6--3 \[[@pone.0233153.ref058]\]. For all other analyses, we used SPSS v25 (IBM; Armonk, New York, USA). SEM analyses were performed by analyzing the covariance matrix of the symptom measures using maximum likelihood estimation. Factor intercorrelations were freely estimated in each model. As is customary, the first indicator of every factor (i.e. the uppermost indicator in [Fig 1](#pone.0233153.g001){ref-type="fig"}) was fixed at 1. Errors were not allowed to correlate. No post hoc modifications of the models were carried out.

![Six classification models for symptoms.](pone.0233153.g001){#pone.0233153.g001}

As the data do not follow a multivariate normal distribution, we applied Satorra-Bentler scaled *χ*^*2*^-statistics (*SB- χ*^*2*^; \[[@pone.0233153.ref059]\]) and related robust fit indices. With a larger sample size, (scaled) *χ*^*2*^ becomes increasingly sensitive to very small model-data discrepancies. Therefore, we focused on additional fit indices, which are less influenced by sample size. The following indices with cutoff values following the recommendations of Hu and Bentler \[[@pone.0233153.ref060]\] and Schermelleh-Engel, Moosbrugger, and Müller \[[@pone.0233153.ref061]\] are reported: (a) comparative fit index (*CFI* ≥ .95 acceptable, ≥ .97 good), (b) Tucker-Lewis index (*TLI* ≥ .95 acceptable, ≥ .97 good), (c) root mean square error of approximation (*RMSEA* ≤ .08 acceptable, ≤ .05 good), (d) standardized root mean square residual (*SRMR* \< .10 acceptable, \< .05 good), and (e) Akaike Information Criterion, *AIC*, and Bayes Information Criterion, *BIC* (no cutoff values, smaller values indicate better fit). For RMSEA, the 90% confidence interval is also reported. If the lower bound of this confidence interval is 0, the hypothesis of "exact-fit" (i.e. the null hypothesis that RMSEA in the population is 0) is retained (α = 0.05). In addition, the less stringent "close-fit hypothesis" (i.e. the null hypothesis that RMSEA in the population is less than or equal to .05) is tested. A p-value (denoted as *p*~close~) of this test greater than α (i.e. statistically insignificant) supports the model. In addition to the global fit measures, we present the fully standardized solution of the best-fitting model. Significance tests of parameter estimates are based on robust standard errors (i.e. the MLM estimator in lavaan). These analyses were repeated with a restricted sample (*n* = 465) which did not indicate primary shape and weight concerns in the FKS (scores ≤ 2 \[scaled 0 "not at all" to 4 "very strongly so"\] on item 3 "Is your main concern about your appearance that you are not thin enough or could become fat?").

If the best-fitting model shows an acceptable fit and the estimated parameters are as expected, the equivalence of the model in the male and female subsamples can be tested using multi-group SEM. In a first step, the model is tested for men and women separately. If the model fits well in both subsamples, one proceeds with a series of hierarchically nested models which allow increasingly stronger forms of invariance to be examined \[[@pone.0233153.ref062]\].

The first multi-group model is the baseline model, in which all parameters in both groups are freely estimated. A good fit of this baseline model speaks in favor of configural invariance (Model CI). In this weakest form of invariance, the number of factors and their correspondence to the indicators is the same across both groups. If configural invariance has been established, metric invariance (Model MI) can be examined. In this step, all factor loadings are constrained to be equal in both groups. Compared to the baseline model, this nested restricted model should not be statistically worse, i.e. the Δ*SB- χ*^*2*^ test \[[@pone.0233153.ref063]\] should be non-significant. Furthermore, global fit should not practically decline too much. Following Chen \[[@pone.0233153.ref064]\], the cutoffs for a practically significant decrease in fit employed here are Δ*CFI* ≤ -0.01, supplemented by Δ*RMSEA* ≥ 0.015, or Δ*SRMR* ≥ 0.03 (where the fit index of the restricted model is always subtracted from the fit index of the unrestricted model). If metric invariance is supported, all indicators contribute to their factor with similar magnitude and one can proceed to test for scalar invariance (Model SI). For this purpose, the intercepts are additionally constrained to be equal across the two groups. Again, the restricted model (Model SI) is then compared to the less restricted model (Model MI) and the cutoff values proposed by Chen \[[@pone.0233153.ref064]\] are applied, which are identical to those above with the exception of Δ*SRMR*, which requires Δ*SRMR* ≥ 0.01. If scalar invariance can be established, it is possible to compare means on the latent factors between men and women.

Results {#sec008}
=======

Participants' demographic {#sec009}
-------------------------

Our total sample consisted of 736 participants. Of those, 153 (20.8%; *M*~age~ = 29.01 years, *SD*~age~ = 11.64; *Min*~*age*~ = 18, *Max*~*age*~ = 61) were male and 583 (79.2%; *M*~age~ = 24.92, *SD*~age~ = 8.18; *Min*~*age*~ = 18, *Max*~*age*~ = 73) were female.

Model fits {#sec010}
----------

For all symptom scales, the respective items were averaged over non-missing data. None of the symptom scales had more than three missing values (\<0.03%), with only 34 missing values across all items and scales in total (\<0.03%). [Table 1](#pone.0233153.t001){ref-type="table"} displays means, standard deviations, and reliability information of the symptom scales. The bivariate product moment correlations *r* between the symptom scales are presented in [Table 2](#pone.0233153.t002){ref-type="table"}. Since data were not bivariate normally distributed we employed bootstrapping instead of the standard parametric significance tests for r (against 0, percentile method, 1000 samples).

10.1371/journal.pone.0233153.t002

###### Pearson correlations between symptom measures.
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              FKS                                         EDE-Q                                       PHQ-9                                       OCI-R                                       mSHAI                                       HEALTH-49                                   LSAS                                        MDDI                                        SPS-R                                       MGHHPS                                      ACQ
  ----------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- -------------------------------------------
  FKS                                                     .540[\*](#t002fn002){ref-type="table-fn"}   .390[\*](#t002fn002){ref-type="table-fn"}   .346[\*](#t002fn002){ref-type="table-fn"}   .363[\*](#t002fn002){ref-type="table-fn"}   .311[\*](#t002fn002){ref-type="table-fn"}   .373[\*](#t002fn002){ref-type="table-fn"}   .521[\*](#t002fn002){ref-type="table-fn"}   .274[\*](#t002fn002){ref-type="table-fn"}   -.002                                       .350[\*](#t002fn002){ref-type="table-fn"}
  EDE-Q       .798[\*](#t002fn002){ref-type="table-fn"}                                               .379[\*](#t002fn002){ref-type="table-fn"}   .278[\*](#t002fn002){ref-type="table-fn"}   .309[\*](#t002fn002){ref-type="table-fn"}   .323[\*](#t002fn002){ref-type="table-fn"}   .346[\*](#t002fn002){ref-type="table-fn"}   .542[\*](#t002fn002){ref-type="table-fn"}   .226[\*](#t002fn002){ref-type="table-fn"}   .041                                        .333[\*](#t002fn002){ref-type="table-fn"}
  PHQ-9       .538[\*](#t002fn002){ref-type="table-fn"}   .536[\*](#t002fn002){ref-type="table-fn"}                                               .489[\*](#t002fn002){ref-type="table-fn"}   .404[\*](#t002fn002){ref-type="table-fn"}   .557[\*](#t002fn002){ref-type="table-fn"}   .572[\*](#t002fn002){ref-type="table-fn"}   .353[\*](#t002fn002){ref-type="table-fn"}   .244[\*](#t002fn002){ref-type="table-fn"}   .127[\*](#t002fn002){ref-type="table-fn"}   .518[\*](#t002fn002){ref-type="table-fn"}
  OCI-R       .373[\*](#t002fn002){ref-type="table-fn"}   .344[\*](#t002fn002){ref-type="table-fn"}   .484[\*](#t002fn002){ref-type="table-fn"}                                               .406[\*](#t002fn002){ref-type="table-fn"}   .387[\*](#t002fn002){ref-type="table-fn"}   .457[\*](#t002fn002){ref-type="table-fn"}   .280[\*](#t002fn002){ref-type="table-fn"}   .209[\*](#t002fn002){ref-type="table-fn"}   .012                                        .399[\*](#t002fn002){ref-type="table-fn"}
  mSHAI       .383[\*](#t002fn002){ref-type="table-fn"}   .340[\*](#t002fn002){ref-type="table-fn"}   .413[\*](#t002fn002){ref-type="table-fn"}   .428[\*](#t002fn002){ref-type="table-fn"}                                               .480[\*](#t002fn002){ref-type="table-fn"}   .377[\*](#t002fn002){ref-type="table-fn"}   .268[\*](#t002fn002){ref-type="table-fn"}   .236[\*](#t002fn002){ref-type="table-fn"}   .043                                        .414[\*](#t002fn002){ref-type="table-fn"}
  HEALTH-49   .425[\*](#t002fn002){ref-type="table-fn"}   .405[\*](#t002fn002){ref-type="table-fn"}   .621[\*](#t002fn002){ref-type="table-fn"}   .391[\*](#t002fn002){ref-type="table-fn"}   .457[\*](#t002fn002){ref-type="table-fn"}                                               .431[\*](#t002fn002){ref-type="table-fn"}   .285[\*](#t002fn002){ref-type="table-fn"}   .198[\*](#t002fn002){ref-type="table-fn"}   .076                                        .529[\*](#t002fn002){ref-type="table-fn"}
  LSAS        .480[\*](#t002fn002){ref-type="table-fn"}   .446[\*](#t002fn002){ref-type="table-fn"}   .600[\*](#t002fn002){ref-type="table-fn"}   .438[\*](#t002fn002){ref-type="table-fn"}   .343[\*](#t002fn002){ref-type="table-fn"}   .427[\*](#t002fn002){ref-type="table-fn"}                                               .362[\*](#t002fn002){ref-type="table-fn"}   .228[\*](#t002fn002){ref-type="table-fn"}   .065                                        .556[\*](#t002fn002){ref-type="table-fn"}
  MDDI        .676[\*](#t002fn002){ref-type="table-fn"}   .684[\*](#t002fn002){ref-type="table-fn"}   .451[\*](#t002fn002){ref-type="table-fn"}   .325[\*](#t002fn002){ref-type="table-fn"}   .307[\*](#t002fn002){ref-type="table-fn"}   .394[\*](#t002fn002){ref-type="table-fn"}   .426[\*](#t002fn002){ref-type="table-fn"}                                               .149[\*](#t002fn002){ref-type="table-fn"}   -.012                                       .275[\*](#t002fn002){ref-type="table-fn"}
  SPS-R       .271[\*](#t002fn002){ref-type="table-fn"}   .202[\*](#t002fn002){ref-type="table-fn"}   .303[\*](#t002fn002){ref-type="table-fn"}   .239[\*](#t002fn002){ref-type="table-fn"}   .188[\*](#t002fn002){ref-type="table-fn"}   .262[\*](#t002fn002){ref-type="table-fn"}   .267[\*](#t002fn002){ref-type="table-fn"}   .177[\*](#t002fn002){ref-type="table-fn"}                                               .187[\*](#t002fn002){ref-type="table-fn"}   .255[\*](#t002fn002){ref-type="table-fn"}
  MGHHPS      .073[\*](#t002fn002){ref-type="table-fn"}   .088[\*](#t002fn002){ref-type="table-fn"}   .123[\*](#t002fn002){ref-type="table-fn"}   .045                                        .026                                        .077[\*](#t002fn002){ref-type="table-fn"}   .079[\*](#t002fn002){ref-type="table-fn"}   .102[\*](#t002fn002){ref-type="table-fn"}   .152[\*](#t002fn002){ref-type="table-fn"}                                               .065
  ACQ         .453[\*](#t002fn002){ref-type="table-fn"}   .402[\*](#t002fn002){ref-type="table-fn"}   .556[\*](#t002fn002){ref-type="table-fn"}   .422[\*](#t002fn002){ref-type="table-fn"}   .455[\*](#t002fn002){ref-type="table-fn"}   .562[\*](#t002fn002){ref-type="table-fn"}   .554[\*](#t002fn002){ref-type="table-fn"}   .387[\*](#t002fn002){ref-type="table-fn"}   .252[\*](#t002fn002){ref-type="table-fn"}   .087[\*](#t002fn002){ref-type="table-fn"}   

Correlations from full sample (N = 736) below the diagonal and from restricted sample (N = 465) above the diagonal.

\* p \< .05 (two-tailed) applying bootstrapping. FKS, Body Dysmorphic Symptoms Inventory (Fragebogen Körperdsysmorphe Störung); EDE-Q, Eating Disorder Examination-Questionnaire; PHQ-9, Patient Health Questionnaire depression module; OCI-R, Obsessive-Compulsive Inventory-Revised; mSHAI, Short Health Anxiety Inventory, modified version; HEALTH-49, Hamburg Modules for the Assessment of Psychosocial Health, short version; LSAS, Liebowitz Social Anxiety Scale; MDDI, Muscle Dysmorphia Disorder Inventory; SPS-R, Skin Picking Scale-Revised; MGHHPS, Massachusetts General Hospital Hairpulling Scale; ACQ, Agoraphobic Cognitions Questionnaire.

Global SEM fit indices of the six classification models (as presented in [Fig 1](#pone.0233153.g001){ref-type="fig"}) are shown in [Table 3](#pone.0233153.t003){ref-type="table"}. The results reveal a very clear picture, with the 4-factor Body Image model (BIM) outperforming the other competing models. All global fit indices of the BIM indicated a good fit (*CFI* = 0.972, *RMSEA* = 0.049, *SRMR* = 0.027) or an acceptable fit (*TLI* = 0.959). According to the cutoffs reported above, none of the competing models yielded an acceptable fit on any of the fit measures with the exception of *SRMR*. Furthermore, the BIM showed a statistically better fit to the data than the general psychopathology model, Δ*SB-χ*^*2*^(6) = 277.24, *p* \< .001. Since they are not nested, the BIM and the remaining models could only be compared by means of *AIC* and *BIC*. The BIM produced the lowest *AIC* and *BIC* values of all models, again indicating the best relative fit.

10.1371/journal.pone.0233153.t003

###### SEM fit statistics for six competing models in the complete sample.
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  Model         *SB*-χ^2^                                           *df*   *CFI*   *TLI*   *RMSEA* \[90% CI\]       *p*~*close*~   *SRMR*   *AIC*        *BIC*
  ------------- --------------------------------------------------- ------ ------- ------- ------------------------ -------------- -------- ------------ ------------
  1 Gen.Patho   500.695 [\*\*\*](#t003fn002){ref-type="table-fn"}   44     0.805   0.757   0.119 \[0.111, 0.127\]   .00            0.068    12,543.647   12,644.874
  2 Somato.     501.266 [\*\*\*](#t003fn002){ref-type="table-fn"}   41     0.804   0.737   0.124 \[0.115, 0.132\]   .00            0.068    12,534.983   12,650.014
  3 OCRD        457.312 [\*\*\*](#t003fn002){ref-type="table-fn"}   41     0.822   0.762   0.117 \[0.109, 0.126\]   .00            0.071    12,483.153   12,598.183
  4 Affective   486.446 [\*\*\*](#t003fn002){ref-type="table-fn"}   41     0.810   0.745   0.121 \[0.113, 0.130\]   .00            0.069    12,509.634   12,624.665
  5 BIM         104.096 [\*\*\*](#t003fn002){ref-type="table-fn"}   38     0.972   0.959   0.049 \[0.039, 0.059\]   .57            0.027    12,007.593   12,136.427
  6 BDD         413.851 [\*\*\*](#t003fn002){ref-type="table-fn"}   38     0.840   0.768   0.116 \[0.107, 0.125\]   .00            0.059    12,411.997   12,540.832

*N* = 736. Gen.Patho., General Psychopathology Model; Somato., Somatoform Model; OCRD, Obsessive-Compulsive and Related Disorders Model; Affective, Affective Model; BIM, Body Image Model; BDD, Body Dysmorphic Disorder Model.

\*\*\* *p* \< .001

The BIM with completely standardized parameter estimates is shown in [Fig 2](#pone.0233153.g002){ref-type="fig"}. As expected, all factor loadings were positive and statistically significant (*p* \< .01). The smallest loading was exhibited by the symptom "Hair pulling" on the factor "Impulse-control". All latent intercorrelations between the four factors were positive and statistically significant (*p* \< .01). Notably, the correlation between the factors "Affective" and "Somatoform" was very high (ρ = 0.93, *p* \< .001).

![Completely standardized parameter estimates for the body image model.](pone.0233153.g002){#pone.0233153.g002}

Gender invariance of the body image model {#sec011}
-----------------------------------------

Building on the preceding results, the invariance analyses refer to the best-fitting BIM. Testing this model for both groups separately revealed good to acceptable fit for men and women (see [Table 4](#pone.0233153.t004){ref-type="table"}). With one exception, all factor loadings were higher than 0.56 (completely standardized loadings, λ\*) and statistically significant, *p* \< .001. The exception was the loading of the symptom "Hair pulling" on the factor "Impulse-control" (women: λ\* = 0.20, *p* \< .05; men: λ\* = 0.45, *p* \< .01), which was also the lowest-loading symptom in the total sample.

10.1371/journal.pone.0233153.t004

###### Model fit for invariance models.
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  Model   Invariance       SB-χ^2^                                            df   CFI     TLI     RMSEA \[90% CI\]         SRMR
  ------- ---------------- -------------------------------------------------- ---- ------- ------- ------------------------ -------
  M       \-               48.381                                             38   0.971   0.958   0.042 \[0.000, 0.071\]   0.045
  F       \-               109.961[\*\*\*](#t004fn002){ref-type="table-fn"}   38   0.964   0.948   0.057 \[0.046, 0.068\]   0.033
  CI      configural       158.152[\*\*\*](#t004fn002){ref-type="table-fn"}   76   0.963   0.946   0.054 \[0.044, 0.065\]   0.033
  MI      metric           174.555[\*\*\*](#t004fn002){ref-type="table-fn"}   83   0.958   0.945   0.055 \[0.045, 0.065\]   0.044
  PMI     partial metric   162.626[\*\*\*](#t004fn002){ref-type="table-fn"}   82   0.963   0.951   0.052 \[0.041, 0.062\]   0.037
  SI      scalar           203.365[\*\*\*](#t004fn002){ref-type="table-fn"}   90   0.948   0.937   0.059 \[0.049, 0.068\]   0.045
  PSI     partial scalar   197.082[\*\*\*](#t004fn002){ref-type="table-fn"}   89   0.951   0.939   0.057 \[0.048, 0.067\]   0.041

*N* = 736 for all models except F and M. *N*~*F*~ = 583 (female), *N*~*M*~ = 153 (male).

\*\*\* *p* \< .001

In the next step, parameters in both groups were estimated simultaneously. This baseline model yielded an acceptable fit, which speaks in favor of configural invariance and justifies the evaluation of more restrictive invariance models. The constraint of equal factor loadings in both groups produced a statistically significant increase in misfit (Model MI compared to Model CI, see [Table 5](#pone.0233153.t005){ref-type="table"}). This speaks against metric invariance. On the other hand, the decrease in fit of the other indices was small and below the cutoff values proposed by Chen \[[@pone.0233153.ref064]\]. When examining the freely estimated loadings of the baseline model in detail, it became evident that in particular, the estimate of the path from the factor "Affective syndrome" to the "Obsessive-compulsive" symptoms diverged in the two subsamples. Therefore, we tested a model for partial metric invariance (Model PMI) with this path being freely estimated in both groups \[[@pone.0233153.ref065]\]. Freeing this loading resulted in a stronger standardized path for men (λ\* = 0.710) than for women (λ\* = 0.574). Compared to the baseline model, no statistically and no practically significant increase in misfit occurred.

10.1371/journal.pone.0233153.t005

###### Model comparisons for invariance models.
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  Model   Invariance       ΔSB-χ^2^   Δdf   *p*     ΔCFI     ΔRMSEA   ΔSRMR
  ------- ---------------- ---------- ----- ------- -------- -------- -------
  MI      metric           16.231     7     0.023   −0.005   0.001    0.011
  PMI     partial metric   5.094      6     0.532   0.000    −0.002   0.004
  SI      scalar           37.191     7     0.000   −0.010   0.004    0.001
  PSI     partial scalar   47.056     7     0.000   −0.012   0.005    0.004

*N* = 736. *p* = *p*-value of ΔSB-χ^2^ test. Models MI and PMI are compared to model CI, model SI is compared to model MI, and model PSI is compared to model PMI.

As we obtained at least partial support for metric invariance, we also tested for scalar invariance (Model SI). Using the metric and the partial metric invariance model as bases, we constrained the intercepts to be equal across both groups. For both constrained models (SI and PSI, see [Table 5](#pone.0233153.t005){ref-type="table"}), the scaled *SB- χ*^*2*^ difference tests indicated significant increases in misfit. For model PSI, Δ*CFI* slightly exceeded the cutoff value. The change in the other model fit indices for models SI and PSI remained below the cutoffs. Although the results are somewhat inconsistent, there was not sufficient evidence to assume scalar invariance of the BIM in male and female subsamples. Thus, the BIM model demonstrated configural invariance and partial metric invariance. This means that the basic correspondence of symptoms to the underlying four factors is similar in men and women.

Replication of model fits in a sample without primary shape and weight concerns {#sec012}
-------------------------------------------------------------------------------

For the restricted sample of participants who indicated that their main appearance concern did not refer to weight and/or shape, the correlations between the symptom scales are displayed above the diagonal in [Table 2](#pone.0233153.t002){ref-type="table"}. We compared the six competing models in the same way as for the complete sample. From [Table 6](#pone.0233153.t006){ref-type="table"}, it is apparent that the results of the SEM analyses showed the same pattern. The BIM fitted the data well, and better than all other models. Invariance analyses were not replicated, since the sample size of men in the restricted sample was only *n* = 112. Furthermore, for some models, improper SEM solutions emerged.

10.1371/journal.pone.0233153.t006

###### SEM fit statistics for six competing models, restricted sample due to exclusion of primary shape and weight concerns.
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  Model         SB-χ^2^                                            df   CFI     TLI     RMSEA \[90% CI\]         p~close~   SRMR    AIC         BIC
  ------------- -------------------------------------------------- ---- ------- ------- ------------------------ ---------- ------- ----------- -----------
  1 Gen.Patho   188.082[\*\*\*](#t006fn003){ref-type="table-fn"}   44   0.852   0.814   0.084 \[0.073, 0.095\]   .00        0.064   6,658.528   6.749.653
  2 Somato.     186.069[\*\*\*](#t006fn003){ref-type="table-fn"}   41   0.851   0.799   0.087 \[0.076, 0.099\]   .00        0.061   6,649.603   6,753.154
  3 OCRD        173.078[\*\*\*](#t006fn003){ref-type="table-fn"}   41   0.864   0.817   0.083 \[0.072, 0.094\]   .00        0.063   6,643.321   6,746.872
  4 Affective   180.511[\*\*\*](#t006fn003){ref-type="table-fn"}   41   0.856   0.807   0.086 \[0.074, 0.097\]   .00        0.060   6,639.713   6,743.263
  5 BIM         54.462 [\*](#t006fn002){ref-type="table-fn"}       38   0.983   0.975   0.031 \[0.011, 0.046\]   .98        0.029   6.483.638   6,599.616
  6 BDD         140.840[\*\*\*](#t006fn003){ref-type="table-fn"}   38   0.894   0.847   0.076 \[0.064, 0.088\]   .00        0.055   6,592.086   6,708.063

*N* = 465. Gen.Patho., General Psychopathology Model; Somato., Somatoform Model; OCRD, Obsessive-Compulsive and Related Disorders Model; Affective, Affective Model; BIM, Body Image Model; BDD, Body Dysmorphic Disorder Model

\* *p* \< .05

\*\*\* *p* \< .001

Discussion {#sec013}
==========

The present study sought to provide an empirically based recommendation for a future classification of body dysmorphic disorder. To this aim, different classification models, i.e. with BDD symptoms being allocated to different diagnostic categories (somatoform, OCRD, affective, body image and BDD model), were tested using a structural equation modeling approach in a community-based sample of adults. Additionally, gender differences in model fits were examined.

Interestingly, neither the model that conceptualized BDD symptoms within an OCRD category nor the model with BDD symptoms as a stand-alone factor showed a satisfactory fit to the data. For the OCRD model, this strongly contradicts the current classification of BDD as a disorder in the DSM-5 \[[@pone.0233153.ref006]\] and the proposed classification in the ICD-11 \[[@pone.0233153.ref007]\] as well as studies highlighting similarities between OCD and BDD \[[@pone.0233153.ref066]\]. However, other empirical studies have also revealed large differences in phenomenology as well as in clinical and personality characteristics between BDD and other diagnoses of the category such as skin picking, hair pulling, or hoarding, and their combination within one category has received a great deal of criticism \[[@pone.0233153.ref023]\]. With regard to the model that proposes BDD symptoms to be a stand-alone factor, the findings of the present study are in contrast to those of Schneider and colleagues \[[@pone.0233153.ref039]\], who found this to be the best-fitting model. Schneider and colleagues \[[@pone.0233153.ref039]\] argued that there might be symptoms that stand out as unique in BDD in adolescents, e.g. the extent of delusionality with which beliefs are held, which are not mirrored in other disorders. While the same symptoms might still be unique in adulthood, further comorbidities might have led to a more inclusive picture of phenomenology. This assumption is supported by the finding that comorbid diagnoses (e.g. depression, SAD, OCD, and certain eating disorders such as bulimia nervosa) most often develop only after the onset of BDD \[[@pone.0233153.ref067]--[@pone.0233153.ref071]\]. Thus, while the main symptoms do not seem to differ between adolescents and adults \[[@pone.0233153.ref072]\], comorbidity patterns might change, impacting the recommendations for an ideal classification.

Furthermore, both models including BDD symptoms in an affective or a somatoform model did not show an adequate fit, despite previous evidence of similarities between BDD and anxiety disorders (particularly SAD) and depression, as well as high comorbidity rates \[[@pone.0233153.ref028], [@pone.0233153.ref073]\]. At first glance, this is in contrast to previous findings which confirmed higher-order dimensions consisting of a whole range of internalizing (primarily emotional) disorders and externalizing syndromes, as proposed and first identified by Krueger in youth \[[@pone.0233153.ref074]\] and in adults \[[@pone.0233153.ref075]\]. However, a later study showed that this model is not developmentally stable and robust against the addition of further disorders, including eating disorders and somatoform disorders \[[@pone.0233153.ref076]\], which supports the current findings. Regarding the somatoform model, our findings are in accordance with empirical evidence showing little similarity between BDD and other disorders in the category, despite sharing a focus on the body \[[@pone.0233153.ref015]\]. Moreover, they further support the move of the diagnosis out of the DSM-IV \[[@pone.0233153.ref005]\] category Somatoform Disorders with the introduction of the DSM-5 \[[@pone.0233153.ref006]\].

Surprisingly, the model in which BDD symptoms are part of a body image disorders spectrum showed the best fit. This finding remained when the sample was reduced to those participants who indicated primary concerns other than shape and weight in the FKS. These participants were analyzed separately in order to prevent an overestimation of the correlation between ED and BDD symptom levels due to shared symptoms such a checking, avoidance, and behaviors to change the body such as dieting. This corroborates previous findings on the comparability of EDs and BDD on a whole range of clinical, personality, and cognitive variables \[[@pone.0233153.ref030]\]. Regarding non-clinical samples, Samad and colleagues \[[@pone.0233153.ref077]\] found that while ED and BDD symptoms appear to track together, they seem to identify different sets of psychopathological features. This supports our results that the two symptomatologies might best be captured under one category. Furthermore, such a classification would also accommodate the discussion around the BDD subtype MD, which was conceptualized as a variant of eating disorders in earlier research \[[@pone.0233153.ref033]\] and which shows great phenomenological similarities with eating disorders (e.g. dieting \[[@pone.0233153.ref078]\]). As a consequence, several authors have suggested a body image model incorporating the eating disorders with a clear reference to body image (e.g. anorexia and bulimia nervosa and potentially binge eating disorder) together with BDD and MD (e.g. \[[@pone.0233153.ref036], [@pone.0233153.ref079]\]). Disorders falling in such a category would be characterized by a body image disturbance, involving an affective component such as body dissatisfaction, a misperception of the body, cognitive distortions such as attention and interpretation biases, and behaviors such as checking, avoidance, and appearance fixing \[[@pone.0233153.ref080], [@pone.0233153.ref081]\]. Thus, these disorders might present with symptoms also present in other disorders such as sadness or OCD-like checking, but they are all exclusively related to the body. Disorders within this category might be most easily differentiated by examining the body parts individuals are most dissatisfied with, i.e., body zones typically linked to weight concerns in EDs, particularly anorexia nervosa, whereas facial features, hair and skin in BDD \[[@pone.0233153.ref082]\].

The body image model also achieved partial metric invariance, but not scalar invariance, across gender when the path from the factor "affective syndrome" to "OCD symptoms" was freed. The findings suggest that "affective syndrome" influences OCD symptoms more strongly in men than in women. This is in line with the analysis of the comorbidity structure of OCD in the two genders, which hints at a stronger comorbid presentation with affective disorders in men, and a stronger association of the religious obsessive-compulsive dimension (which is more typical in men) with depression (e.g. \[[@pone.0233153.ref083]\]). In sum, the basic correspondence of symptoms to the underlying four factors is similar in men and women. While this is in contrast to the findings of comparable studies for eating disorders (e.g. \[[@pone.0233153.ref084]\]), these findings might be due to the more equally distributed prevalence of BDD across gender compared to EDs (e.g. \[[@pone.0233153.ref004], [@pone.0233153.ref085]\]). Furthermore, this finding is also in contrast to the study by Schneider and colleagues \[[@pone.0233153.ref039]\], who did not find metric invariance for their best-fitting model with the stand-alone BDD factor in adolescents. Developmental tasks in adolescence (e.g. findings one's own gender identity; \[[@pone.0233153.ref086]\]) might be more gender-specific than tasks in early or middle adulthood, thus leading to gender-specific differences in the development of comorbidities.

The present findings need to be interpreted in the light of the strengths and limitations of the study. Limitations pertaining to the sample might lie in the recruitment of a community-based, non-clinical sample, as in particular, the structures of pathology and comorbidity may differ in clinical samples \[[@pone.0233153.ref087]\]. Along the same lines, we have only examined BDD symptoms independent of those warranting a diagnosis of BDD. Therefore, it might be advisable to replicate these findings in a clinical sample with subthreshold levels of symptoms looking into the comorbidity structure at the disorder level. Furthermore, participants were not recruited at random, which might limit generalizability of findings. Additionally, the sizes of the female and male samples differed substantially, meaning that gender differences between groups should be interpreted with caution. Moreover, the high level of education of the sample limits the ability to generalize the findings to persons with a more diverse educational background. Finally, from a design point of view, while the data-driven bottom-up approach of the present study can be criticized, it did allow for the identification of symptom clusters and the examination of empirically derived models. Also, as can be seen from [Fig 1](#pone.0233153.g001){ref-type="fig"}, some factors were assessed only by few indicator variables. In general, simulations show that more indicators per factor result in fewer nonconverged solutions, fewer improper solutions and more accurate parameter estimates (MBR; \[[@pone.0233153.ref088]\]). But simulations demonstrate as well that a low number of indicators can be compensated by larger sample size, e.g. N ≥ 400 \[[@pone.0233153.ref061]\]. Moreover, there were no signs of nonconvergent or improper solutions in any of our models. Taken together, we found no evidence that the relatively low number of indicators has caused problems. The strengths of the study include the large sample size, the broad age range and the use of validated self-report instruments covering a broad spectrum of psychopathology.

This is the first study to examine the empirical evidence for different classification models of BDD in adults, revealing a clear superiority of a body image model of BDD, MD, and eating disorders. Despite this highly important finding, it is of note, that besides this rather categorical approach of classification, recently, a dimensional one has been proposed and highly researched. Along the lines of the initiative Research Domain Criteria (RDoC) of the National Institute of Mental Health (e.g., \[[@pone.0233153.ref089]\]), researchers aim to organize mental disorders not only based on symptoms and behaviors presented but rather along domains of human functioning such as negative valence or cognition that can be measured rather diversely (e.g., self-report vs. on a physiological or a genetic level). Thus, future research might also want to be focused on finding common psychopathological organizers of BDD with other disorders and examine where BDD lies on these dimensions measured with different instruments, respectively.

Our findings have several clinical and research implications. From a clinical perspective, the results highlight the relatedness of EDs and BDD. Although BDD and eating disorders are also often comorbid \[[@pone.0233153.ref090]--[@pone.0233153.ref092]\], BDD might still go unnoticed in practice because eating disorders, particularly anorexia nervosa, might be more evident at first glance. As such, the present findings might be useful for clinicians and might lead to an improvement in the under-diagnosis of this severe mental disorder \[[@pone.0233153.ref093]\]. The better fit of a body image model of eating disorders may suggest that treatment techniques which bring about change in EDs might also be used in BDD. This transfer may lead to promising new avenues to tackle BDD. One such technique (e.g. mirror exposure) has already been successfully applied in BDD (e.g. \[[@pone.0233153.ref094]\]). In the next step, improvement of treatments could be informed by treatment of the respective other disorder. Furthermore, discussions on the development of the next generation of classification systems should take the present findings into account. With regard to non-clinical samples, the high correlation of symptoms in the present sample highlights the need to address the potentially present other symptom cluster in prevention programs. In terms of research implications, the findings need to be replicated in a clinical sample of patients with BDD. Finally, our findings should foster research comparing BDD with other disorders, in particular eating disorders, in order to establish a clear picture of similarities and differences.
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Third, in connection with the above, it is true, as the authors say, that there is no research about the relationship between somatization and BDD. It may be necessary to point out components of somatization that must be taken into account in order to really discard this relationship. Somatization cannot be analyzed simply from a list of physical complaints. The description of the absorption states that can be seen in both the OCD and the BDD is classic. Precisely for that reason, it is a less analyzed, but proposed psychopathological organizer. It is suggested to review: doi: 10.1016 / j.cpr.2004.08.006 as well as Farina, B., & Liotti, G. (2013). Does a dissociative psychopathological dimension exist? A review on dissociative processes and symptoms in developmental trauma spectrum disorders. Clinical Neuropsychiatry, 10(1), 11--18.

In short, the authors are asked to indicate which psychopathological organizers would conform to the BDD as a body image disorder, close, but differentiable from the Eating Disorders, for example. This contribution could lead the investigation precisely on the mediating and moderating components, and not exclusively on the description of symptoms and behaviors.

Reviewer \#3: The current manuscript employs structural equation modeling (SEM) to identify an empirically supported classification structure for body dysmorphic disorder (BDD). The authors generated six a priori models based on the literature and determined that a Body Image Model provided the best fit structure. This is an important and understudied area of research. Particular strengths of this study, relative to past research on this topic, are the use of SEM with strong theoretically-derived models, large sample size, and a set of well-validated indicator measures. However, there are some concerns with the analyses and suggestions described in more detail below to improve interpretability of the findings.

The authors did a commendable job in their description, justification, and interpretation of all fit indices, and examination of gender invariance and multi-group solutions. However, the main concern with the approach is with variable selection.

There would be an expected level of multicollinearity among indicator variables across the spectrum of psychopathology included in this study, but there is quite substantial collinearity between the FKS and EDE-Q, in particular, at the zero-order level (r = .798), which is only potentially problematic in that suggests there may be redundant information contributing to the "Body Image" factor. Given that this model provided the best fit, I wonder if the authors inspected reasons for this particularly high degree of overlap and considered dropping each of the variables (e.g., EDE-Q) to test its effect on parameter estimates and model fit. Were there other eating disorder inventories/scales included in the online survey? Alternatively, I wonder if there are subscales within the FKS and EDE-Q that particularly hang together driving the overall multicollinearity, which could be examined in further sensitivity analyses to defend the robustness of the Body Image model.

There were few indicator variables (as few as 2) for some of the factors. Please discuss the implications of this on parameter estimation and model comparison.

Another concern is regarding the significant amount of missing data, which is common to survey studies. How were "complete" surveys defined, and were there any attempts made to examine patterns of missingness based on available data collected?

It was clear to me that the six models tested in the current study were derived based on the existing literature; however, to an unfamiliar reader, this may have been unclear. There could be more background on the selection of measures and models included in the study. I also couldn't find figure captions for Figures 1 and 2.

Results on clinical characteristics appear to be missing on p.13.

As the study objective was to examine the structure of BDD, it presents a challenge interpreting data based on a community (non-clinical) sample. The defining feature of BDD is that the physical features are dysmorphic, by nature, which cannot be reliably assessed via self-report. Although the authors already note these limitations in the Discussion, some of the findings are still overstated and I suggest scaling back the language accordingly. In particular, I suggest paying close attention to discussion of the findings with reference to studies conducted in large community samples that estimate the whole continuum of body dysmorphic concerns (and other related pathology). For example, the authors discuss the implications of support for a body image spectrum of classification for BDD but only in the context of clinical studies of BDD, eating disorders, and MD (p.21), rather than in non-clinical, analogue, or community samples.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 0

7 Apr 2020

Dear Reviewers,

Thank you very much for your valuable comments on our manuscript. We have addressed each one of them below and have performed respective changes in the manuscript which have been highlighted in yellow. In the attached coverletter, you can find the response to the Reviewers in a more formatted version also.

Reviewer \#1:

The article describes a procedure used to recommend a classification for body dysmorphic disorder. The article is about a relevant topic, it is well-written and a pleasant reading. It considers appropriate statistical methodologies, which are well described. I have a few questions about the study.

Thank you very much for this favorable evaluation of our study. We have addressed your comments below.

Minor Compulsory Revisions:

1\. Page 7/lines 11-13: Authors described the recruitment process. Since the sample is not at random (even at the institutions of the authors), it would be interesting to discuss the generalization of the results. At page 22 (lines 14-20), the authors mentioned some limitations of the same, but this could be further extended.

This is an important point. We have, therefore, mentioned the missing randomness in recruitment and the resulting limited generalizability of the findings in the discussion section on page 24:

"Furthermore, participants were not recruited at random, which might limit generalizability of findings."

2\. Page 7/ line 12: The participants are 18 years and older. At page 13/lines 6-7: the authors described the mean and standard deviation for age of the participants of the study. It might be important to include the highest age for a better description of the sample, which is cited to have a "broad age range" (page 22/line 24).

We have supplemented this important information in the text on page 13:

"Our total sample consisted of 736 participants. Of those, 153 (20.8%; Mage = 29.01 years, SDage = 11.64; Minage=18, Maxage=61) were male and 583 (79.2%; Mage = 24.92, SDage = 8.18; Minage=18, Maxage=73) were female."

3\. Page 11/line 18: What is the definition of pclose?

Thank you for this chance to clarify the meaning of pclose. pclose is the p-value of the test of the null-hypothesis that RMSEA in the population is ≤ .05. We have now made this clearer by rewriting the relevant section on page 11:

"For RMSEA, the 90% confidence interval is also reported. If the lower bound of this confidence interval is 0, the hypothesis of "exact-fit" (i.e. the null hypothesis that RMSEA in the population is 0) is retained (α = 0.05). In addition, the less stringent "close-fit hypothesis" (i.e. the null hypothesis that RMSEA in the population is less than or equal to .05) is tested. A p-value (denoted as pclose) of this test which is greater than α (i.e. statistically insignificant) supports the model.

4\. Page 13/line 13: (Pearson) bivariate product moment correlations are presented in Table 2. In the footnote of Table 2 (Page 15), statistically significant correlation coefficients are highlighted. As data do not follow a multivariate normal distribution (as mentioned at page 11/line 8), what is the adopted procedure to test the correlations?

In Table 2 standard parametric t-tests were employed. We cross-checked the results of the significance test using bootstrapping (percentile method, 1000 samples). All 110 statistical decisions (statistically significant or not) derived from the parametric test and the bootstrapping procedure were identical except r(FKS, MGHHPS) in the full sample which became statistically significant only using the parametric method. Nevertheless, we now report the results of the bootstrapping tests instead of the parametric test in Table 2 which is introduced on page 13:

"Since data were not bivariate normally distributed we employed bootstrapping instead of the standard parametric significance tests for r (against 0, percentile method, 1000 samples)".

Reviewer \#2: PONE-D-19-15829

It is a very interesting work, very well justified, analyzed and explained. The sample used is large, the instruments used are relevant, the statistical applied are flawless, and the contributions are adequately discussed, including the limitations of the study.

Thank you very much for this positive evaluation of our manuscript. We have answered your important questions and concerns in the following.

The researchers are asked some questions that we consider important from a conceptual point of view. This has to be taken into account, since it is the main direction and contribution of this research.

5\. First of all, one should not speak of BDD but of BDD symptomatology. This should be taken into account because some questionnaires or scales have been administered, but it cannot be confirmed in this way that we are talking about a formal diagnosis. The authors allude precisely to the DSM and ICD, so it is understood that we should talk about a finding of inclusion, exclusion, and impairment criteria identified through a formal diagnostic interview. In this way we could say, strictly speaking, that we are talking about BDD.

Thank you very much for this important remark. Indeed, we aimed to relate BDD psychopathology (but not the disorder as an entity) with other psychopathologies and agree with the Reviewer, that we did not formally diagnose our participants. We have, therefore, rephrased throughout the manuscript as "BDD symptoms".

6\. In relation to the above, the authors are suggested to refer to symptoms of BDD, or sub-threshold BDD or, as expressly referred to by the DSM, dysmorphic concerns. In the same vein, authors are recommended to review a publication that addresses precisely this issue (doi: 10.1002 / ijop.12646).

We are thankful for the comment and the recommendation of this interesting publication. As we have employed the Body Dysmorphic Symptoms Inventory (German: Fragebogen Körperdysmorpher Symptome) which assesses not only dysmorphic concerns but also related behaviors we decided to rephrase as "BDD symptoms" throughout the manuscript.

7\. Secondly, being in full agreement with the authors about the approach adopted, and the results indicated, it is perhaps missing what aspects of body image are relevant here. It may seem tautological that there are disorders where the body and discomfort about it are categorized more precisely as body image disorders. It would be relevant to propose what aspects should lead the investigation if, as proposed, the validity of the construct has more to do with body image than with emotional, obsessive-compulsive symptoms, etc.

Thank you for this chance to clarify the concept of body image and body image disturbance more thoroughly for the readers as well as point out more specifically which aspects seem relevant for a distinct classification in a body image spectrum vs. an emotional, ocd spectrum etc. We follow the definitions of Cash (2004) and Slade (1988) that summarize body image to consist of four components, cognitive, perceptive, affective and behavioral. Thus, disorders that might be categorized in this category are not only characterized by a discomfort about the own body but also about misperceptions, behaviors like checking and avoidance as well as cognitive distortions such as attention or interpretation biases. Thus, symptoms comparable to those in emotional disorder or OCRD might be present but are all related to the body (sadness about the body, compulsive checking the body, etc). We have made this clearer in the discussion section on pages 22-23):

"Disorders falling in such a category would be characterized by a body image disturbance, involving an affective component such as body dissatisfaction, a misperception of the body, cognitive distortions such as attention and interpretation biases, and behaviors such as checking, avoidance, and appearance fixing \[80, 81\]. Thus, these disorders might present with symptoms also present in other disorders such as sadness or OCD-like checking, but they are all exclusively related to the body."

8\. Third, in connection with the above, it is true, as the authors say, that there is no research about the relationship between somatization and BDD. It may be necessary to point out components of somatization that must be taken into account in order to really discard this relationship. Somatization cannot be analyzed simply from a list of physical complaints. The description of the absorption states that can be seen in both the OCD and the BDD is classic. Precisely for that reason, it is a less analyzed, but proposed psychopathological organizer. It is suggested to review: doi: 10.1016 / j.cpr.2004.08.006 as well as Farina, B., & Liotti, G. (2013). Does a dissociative psychopathological dimension exist? A review on dissociative processes and symptoms in developmental trauma spectrum disorders. Clinical Neuropsychiatry, 10(1), 11--18.

Thank you very much for the recommendation of these interesting reads. Indeed, this is a potential psychopathological organizer that might link the disorders. We have provided this information now in our introduction, also in order with Reviewer \#3' suggestion (see comment \#14) to strengthen the empirical basis of our models. See page 4 of the manuscript:

"On the other hand, several somatoform disorders and BDD \[17, 18\] amongst other disorders share a heightened likelihood for dissociation and thus might be linked via dissociation as a psychopathological organizer \[19, 20\].

9\. In short, the authors are asked to indicate which psychopathological organizers would conform to the BDD as a body image disorder, close, but differentiable from the Eating Disorders, for example. This contribution could lead the investigation precisely on the mediating and moderating components, and not exclusively on the description of symptoms and behaviors.

We agree with the Reviewer that psychopathological organizers are highly relevant, in particular when following a non-categorical but rather dimensional approach, e.g., as suggested within the Research Domain Criteria (RDoC) approach by the National Institute for Mental Health (NIHM) (Cuthbert, 2015). In line with the Reviewer's suggestion, we believe that is important to mention this alternative approach to classification of mental disorders and highlight it now in the discussion section on pages 24-25:

"Despite this highly important finding, it is of note, that besides this rather categorical approach of classification, recently, a dimensional one has been proposed and highly researched. Along the lines of the initiative Research Domain Criteria (RDoC) of the National Institute of Mental Health (e.g., \[89\]), researchers aim to organize mental disorders not only based on symptoms and behaviors presented but rather along domains of human functioning such as negative valence or cognition that can be measured rather diversely (e.g., self-report vs. on a physiological or a genetic level). Thus, future research might also want to be focused on finding common psychopathological organizers of BDD with other disorders and examine where BDD lies on these dimensions measured with different instruments, respectively."

Furthermore, we have added a recent study that has highlighted that EDs (and in particular anorexia nervosa) and BDD are most easily differentiated by the body part(s) individuals are concerned with (see page 23):

"Disorders within this category might be most easily differentiated by examining the body parts individuals are most dissatisfied with, i.e., body zones typically linked to weight concerns in EDs, particularly anorexia nervosa, whereas facial features, hair and skin in BDD \[82\]."

Reviewer \#3:

The current manuscript employs structural equation modeling (SEM) to identify an empirically supported classification structure for body dysmorphic disorder (BDD). The authors generated six a priori models based on the literature and determined that a Body Image Model provided the best fit structure. This is an important and understudied area of research. Particular strengths of this study, relative to past research on this topic, are the use of SEM with strong theoretically-derived models, large sample size, and a set of well-validated indicator measures. However, there are some concerns with the analyses and suggestions described in more detail below to improve interpretability of the findings.

Thank you very much for your favorable evaluation of our manuscript and your critical comments. We addressed each of the latter below.

10\. The authors did a commendable job in their description, justification, and interpretation of all fit indices, and examination of gender invariance and multi-group solutions. However, the main concern with the approach is with variable selection.

There would be an expected level of multicollinearity among indicator variables across the spectrum of psychopathology included in this study, but there is quite substantial collinearity between the FKS and EDE-Q, in particular, at the zero-order level (r = .798), which is only potentially problematic in that suggests there may be redundant information contributing to the "Body Image" factor. Given that this model provided the best fit, I wonder if the authors inspected reasons for this particularly high degree of overlap and considered dropping each of the variables (e.g., EDE-Q) to test its effect on parameter estimates and model fit. Were there other eating disorder inventories/scales included in the online survey? Alternatively, I wonder if there are subscales within the FKS and EDE-Q that particularly hang together driving the overall multicollinearity, which could be examined in further sensitivity analyses to defend the robustness of the Body Image model.

This is an important remark. Unfortunately, in order to keep the survey as short as possible, we did not have other eating disorder measures.

To test for the robustness of the results we followed your idea and omitted each of the three indicators FKS, EDE-Q, and MDDI successively from the body-image factor in model 5. These following SEM results were obtained (in the following always using the complete sample):

SEM Fit Statistics for models 5 (BIM) with two indicators for the body image factor

Model SB-�2 df CFI TLI RMSEA \[90% CI\] pclose SRMR AIC BIC

complete 104.096\*\*\* 38 0.972 0.959 0.049 \[0.039, 0.059\] .57 0.027 12,007.593 12,136.427

without

FKS 87.169\*\*\* 29 0.966 0.948 0.052 \[0.041, 0.063\] .35 0.028 11,319.933 11,439.565

without EDE-Q 86.668\*\*\* 29 0.967 0.949 0.052 \[0.041, 0.063\] .37 0.027 10.214.924 10,334.556

without MDDI 88.550\*\*\* 29 0.969 0.952 0.053 \[0.042, 0.064\] .32 0.028 11,200.803 11,320.435

It can be seen that all three models (a) show an acceptable to good global fit, (b) which is slightly lower compared to the complete, more complex model and (c) do not differ much among each other with respect to fit. This shows that dropping one of the three indicators do not change the results significantly.

In a second step we took the worst fitting model (the one without FKS) and compared all six models omitting always the indicator FKS. The following results show that model 5 is again clearly superior to any other model:

SEM Fit Statistics for all Models without indicator FKS

Model SB-�2 df CFI TLI RMSEA \[90% CI\] pclose SRMR AIC BIC

1 252.541\*\*\* 35 0.875 0.839 0.092 \[0.083,0.101\] .00 0.053 11,540.394 11,632.419

2 250.697\*\*\* 32 0.874 0.823 0.096 \[0.087, 0.106\] .00 0.051 11,535.138 11,640.966

3 240.262\*\*\* 32 0.880 0.831 0.094 \[0.085, 0.104\] .00 0.052 11,532.415 11,638.244

4 247.242\*\*\* 32 0.876 0.826 0.110 \[0.097, 0.123\] .00 0.050 11,527.104 11,632.932

5 87.169\*\*\* 29 0.966 0.948 0.052 \[0.041, 0.063\] .35 0.028 11,319.933 11,439.565

6 237.418\*\*\* 30 0.880 0.821 0.097 \[0.087, 0.107\] .00 0.049 11,552.218 11,637.249

Together these results speak in favor of the robustness of the results.

A second interesting question is whether the multicollinearity is due especially to one of the subscales of the EDE-Q (there are no subscales for FKS and MDDI). To further investigate this question, we successively left out all items which belong to one of the four subscales (restraint, eating concern, weight concern, shape concern) from the total EDE-Q score. The four reduced total scores (comprised of the items from three out of four subscales) correlate highly among each other (all r's \> .95). Furthermore, they show similar correlations with the other two body image indicator FKS and MDDI, which can be seen here:

Items omitted from EDE-Q subscale

restraint eating concern weight concern shape concern complete

FKS .811 .788 .796 .756 .798

MDDI .692 .683 .686 .638 .684

Taking the reduced total scores as indicators results in the following global fit statistics of SEM:

SEM Fit Statistics for Models 5 (BIM) with reduced total score indicators for EDE-Q.

Model 5 SB-�2 df CFI TLI RMSEA \[90% CI\] pclose SRMR AIC BIC

complete 104.096\*\*\* 38 0.972 0.959 0.049 \[0.039, 0.059\] .57 0.027 12,007.593 12,136.427

without

restraint 101.176\*\*\* 38 0.974 0.962 0.048 \[0.038, 0.058\] .64 0.027 12,023.215 12,152.049

without eating concern 106.658\*\*\* 38 0.971 0.958 0.050 \[0.040, 0.060\] .51 0.028 12,154.677 12,283.511

without weight concern 105.050\*\*\* 38 0.971 0.959 0.049 \[0.039, 0.059\] .55 0.027 11,985.821 12,114.655

without shape concern 102.974\*\*\* 38 0.971 0.958 0.048 \[0.038, 0.058\] .60 0.028 12,064.356 12,193.190

Here, again, all four models differ very little among each other with respect to fit.

Together, the additional analyses show that there is no unique EDE-Q subscale driving the overall multicollinearity. Furthermore, this provides additional evidence for the robustness of the results in favor of the Body Image model.

Given the constraints on overall length of the manuscript, we would not add these additional analyses to the manuscript, unless the Reviewer and/or Editor believe them to be indispensable.

12\. There were few indicator variables (as few as 2) for some of the factors. Please discuss the implications of this on parameter estimation and model comparison.

Thank you very much for bringing this to our attention. We have now provided a discussion on page 24 of the manuscript:

"Also, as can be seen from Figure 1, some factors were assessed only by few indicator variables. In general, simulations show that more indicators per factor result in fewer nonconverged solutions, fewer improper solutions and more accurate parameter estimates (MBR; \[88\]). But simulations demonstrate as well that a low number of indicators can be compensated by larger sample size, e.g. N ≥ 400 \[61\]. Moreover, there were no signs of nonconvergent or improper solutions in any of our models. Taken together, we found no evidence that the relatively low number of indicators has caused problems. "

13\. Another concern is regarding the significant amount of missing data, which is common to survey studies. How were "complete" surveys defined, and were there any attempts made to examine patterns of missingness based on available data collected?

Indeed, the amount of missing data is negligible. None of the symptom scales had more than three missing values (\<0.03%). In total there were only 34 missing values across all items and scales (\<0.03%). Given the small numbers of missing values no particular pattern could be detected.

However, we have included only the survey answers of individuals that have completed all questionnaires that are part of this study. Two questionnaires at the end of the survey were not part of this main study.

We have added respective information in the manuscript on pages 7 and 13:

"(i.e., filled out all questionnaires included in this main manuscript results of two further questionnaires will be reported elsewhere);"

"None of the symptom scales had more than three missing values (\<0.03%), with only 34 missing values across all items and scales in total (\<0.03%)."

14\. It was clear to me that the six models tested in the current study were derived based on the existing literature; however, to an unfamiliar reader, this may have been unclear. There could be more background on the selection of measures and models included in the study. I also couldn't find figure captions for Figures 1 and 2.

Thank you very much for this comment. In line with Reviewer 1 comment \# 8, we have added a bit more empirical information as to why we test the somatoform model as one option. We believe that we have provided the adequate empirical backgrounds including sources for the other potential models. To underline the fact that the potential models are based on empirical or theoretical (past or current classification) data, we have made that clearer right before providing our research question on pages 6-7:

"Based on the reviewed literature, mainly of transdiagnostic studies comparing BDD mostly with OCD, eating disorders, anxiety, and depression as well as the study by Schneider and colleagues \[39\] analyzing psychopathological data in adolescents, but also past and current classification of BDD, six potential classification models were specified"

Furthermore, we shortly summarized that these German instruments selected were chosen based on brevity, representativeness of respective symptomatology, as well as frequency of their use. Due to space constraints we do not provide explanations separately for each questionnaire. See page 8:

"Instruments were chosen based on their brevity, representativeness of symptomatology, and frequency of use."

Additionally, we have included the Figure Captions at the end of the manuscript now (see page 32).

15\. Results on clinical characteristics appear to be missing on p.13.

Thank you very much for catching this mistake. As we have decided to present means and standard deviations of the questionnaire scores in a table, we abstained from presenting it in this section again, but forgot to delete this part of the title, which we now did.

16\. As the study objective was to examine the structure of BDD, it presents a challenge interpreting data based on a community (non-clinical) sample. The defining feature of BDD is that the physical features are dysmorphic, by nature, which cannot be reliably assessed via self-report. Although the authors already note these limitations in the Discussion, some of the findings are still overstated and I suggest scaling back the language accordingly. In particular, I suggest paying close attention to discussion of the findings with reference to studies conducted in large community samples that estimate the whole continuum of body dysmorphic concerns (and other related pathology). For example, the authors discuss the implications of support for a body image spectrum of classification for BDD but only in the context of clinical studies of BDD, eating disorders, and MD (p.21), rather than in non-clinical, analogue, or community samples.

Thank you very much for this important comment. We strengthened the limitation point accordingly on page 24:

"Along the same lines, we have only examined BDD symptoms independent of those warranting a diagnosis of BDD. Therefore, it might be advisable to replicate these findings in a clinical sample with subthreshold levels of symptoms looking into the comorbidity structure at the disorder level."

Furthermore, we have included another publication (besides the Schneider et al. \[2018\] study) that has looked at dysmorphic concerns and ED symptoms in a non-clinical sample that supports our data (see page 22):

"Regarding non-clinical samples, Samad and colleagues \[77\] found that while ED and BDD symptoms seem to track together, they seem to identify different sets of psychopathological features. This supports our results that the two symptomatologies might best be captured under one category."

Also, in line with comment \#5 by Reviewer \#1 we have rephrased BDD throughout the manuscript to BDD symptoms when speaking about our sample, as we did not formally diagnose our participants.

And lastly, we have formulated an implication aspect in the last paragraph that focuses on non-clinical samples (page 25):

"With regard to non-clinical samples, the high correlation of symptoms in the present sample highlights the need to address the potentially present other symptom cluster in prevention programs."

10.1371/journal.pone.0233153.r003
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